Zhuowei Luo | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Mr. Zhuowei Luo | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Hubei University of Chinese Medicine | China

Mr. Zhuowei Luo is an emerging researcher recognized for effectively integrating classical Traditional Chinese Medicine (TCM) theory with modern biomedical science, demonstrating strong expertise in molecular mechanism analysis and advanced metabolomics for chronic disease research. His notable scientific contribution is a co-authored publication in the Journal of Ethnopharmacology (Q2, IF 5.14), where he helped elucidate how Allium macrostemon delays chronic renal failure by modulating the IL-17 signaling pathway and altering tryptophan and glycerophospholipid metabolism. This work represents the first comprehensive study connecting immunological regulation with multi-omics profiling to explain the therapeutic mechanisms of this TCM herb, providing a meaningful model for modernizing traditional medicine through systems biology. His role in the project included designing and validating qPCR primers, conducting network pharmacology to identify key molecular targets, performing metabolomics and transcriptomics data analyses, and carrying out histopathological assessments. Through these contributions, he demonstrated an advanced ability to apply interdisciplinary approaches—combining immunology, pharmacology, and bioinformatics—to uncover mechanistic insights into natural product–based interventions. His research reflects scientific maturity beyond typical early-stage experience and contributes to the growing evidence supporting data-driven modernization of TCM in chronic disease treatment.

Profile : Orcid

Featured Publication

Zhao, Y., Ge, J. X., Zhang, N., Lei, Z. X., Sun, S. Y., Luo, Z. W., Yang, Y. F., & Wu, H. Z. (2025). Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism. Journal of Ethnopharmacology, 120946.

Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Dr. Abdelaziz Ghanemi | Medicine and Dentistry | Best Researcher Award

Laval University | Canada

Author Profile

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Abdelaziz Ghanemi’s academic foundation reflects both intellectual rigor and global engagement. He graduated as the top student from the pharmacy program at Mentouri University of Constantine in Algeria. His quest for advanced scientific knowledge led him to China Pharmaceutical University, where he earned a Master of Science in Pharmacology, completing more than twice the credit requirement. His research there involved high-throughput screening for dopamine D5 receptor ligands—a project using transgenic cell lines and cutting-edge fluorescence assays. He then pursued a Ph.D. in Molecular Medicine at Laval University in Canada. His doctoral thesis was a comprehensive study of gene regulation in obesity and exercise, particularly focusing on TFF2 and SPARC, and was constructed from an impressive 27 peer-reviewed publications, marking an extraordinary achievement in biomedical research.

🧪 Professional Endeavors

Dr. Ghanemi’s professional journey spans Algeria, China, and Canada, covering a spectrum of scientific, academic, and community roles. His appointments include:

👨‍🔬 Postdoctoral Fellowships at CHU de Québec–Université Laval Research Center and LOEX Regenerative Medicine Lab, where he explored obesity, vascular calcification, and 3D bioprinting for tissue engineering.
👨‍🏫 Visiting Scholar at the University of Victoria (2024), working under Prof. Stephanie Willerth on bioprinting applications in regenerative medicine.
🔬 Research Professional at the CHUQ’s Functional Genomics and SAGE platform, applying gene expression tools to decode metabolic and ageing pathways.
🌍 Interpreter and Science Communicator, fluent in Arabic, English, French, and Chinese, enhancing cross-cultural scientific collaboration.

In addition to these, Dr. Ghanemi has participated in numerous internships, including hospital pharmacy and neurobiology labs, and taught pharmacology in China—demonstrating both practical and pedagogical expertise.

🔬 Contributions and Research Focus

Dr. Ghanemi’s research covers some of the most pressing biomedical themes of our time:

🧠 Obesity and metabolism, focusing on gene-environment interactions and exercise-induced molecular changes
💪 Regenerative medicine, especially the roles of SPARC and TFF2 in ageing, obesity, and tissue repair
🧬 Genomic and transcriptomic analysis using transgenic animal models and advanced sequencing platforms
🩺 Chronic kidney disease and mineral bone disorders, examining vitamin D pathways and Wnt/β-catenin signaling

His scholarly productivity includes over 50 scientific articles, a Google Scholar h-index of 22, and contributions to high-impact journals such as Biomedicines, Metabolites, Biology, Medicines, and Cytokine.

🏅 Accolades and Recognition

Dr. Ghanemi’s excellence has been recognized globally:

🥇 “Best Student Award” during his undergraduate pharmacy studies
🏆 Oral Presentation Award at ICOMES & AOCO 2019 in Seoul for research on SPARC and exercise
🎓 Vanier Canada Graduate Scholarship Nominee, one of Canada’s most prestigious honors
💬 “Student Seminar Award” by CHU de Québec Research Center for outstanding research communication
🏅 “I Stand With Her” Award at the Women in Medicine Summit (Chicago), honoring his advocacy for women's health
🌍 Laval University Representative at the Canadian Student Health Research Forum (2021)

These distinctions underscore both the scientific value and societal impact of his work.

🌐 Impact and Influence

Dr. Ghanemi’s influence extends beyond the laboratory. His work on exercise mimetics, bioenergetics, and gene-environment crosstalk holds implications for public health, geriatrics, and personalized medicine. As an editor for a special issue in Biomedicines (2024–2025), he is shaping academic dialogue on metabolism and tissue engineering. His editorial contributions and published opinions have influenced how we view obesity, exercise biology, and post-COVID metabolic health. His multilingual ability and international collaborations make him a bridge between cultures and scientific communities.

🔮 Legacy and Future Contributions

Dr. Ghanemi's trajectory suggests a lasting legacy in translational medicine. His integration of molecular research, clinical relevance, and public health awareness positions him to advance therapeutic development in obesity, regenerative strategies, and age-related diseases. With current projects involving SPARC’s therapeutic applications, vascular biology, and bioprinted tissues, Dr. Ghanemi is at the vanguard of modern biomedical science. His commitment to publishing, mentoring, and interdisciplinary exploration signals continued contributions to global health and scientific progress.

Publications


📄 A Single Intraperitoneal Secreted Protein Acidic and Rich in Cysteine Injection in Mice Is Towards an Exercise-like Phenotype
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Biology
Year: 2025


📄 Obesity and Bone Mineral Density Protection Paradox in Chronic Kidney Disease: Secreted Protein Acidic and Rich in Cysteine as a Piece of the Puzzle?
Authors: Abdelaziz Ghanemi, Fabrice Mac-Way
Journal: Life
Year: 2023


📄 Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2023


📄 Secreted Protein Acidic and Rich in Cysteine (SPARC)—Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Diseases
Year: 2023


📄 DNA Damage as a Mechanistic Link between Air Pollution and Obesity?
Authors: Abdelaziz Ghanemi, Mayumi Yoshioka, Jonny St-Amand
Journal: Medicines
Year: 2022


Panupong Hansrivijit | Health Professions | Best Researcher Award

Dr. Panupong Hansrivijit | Health Professions | Best Researcher Award

Brigham and Women's Hospital | United States

Author Profile

Scopus

Orcid

Google Scholar

🌟 Early Academic Pursuits

Dr. Panupong Hansrivijit embarked on his medical journey at Chulalongkorn University, where he graduated with first-class honors in medicine. His passion for internal medicine and nephrology led him to pursue an internship at Thammasat University Hospital, where he gained extensive clinical experience in patient care and medical procedures. This strong academic foundation set the stage for his future endeavors in nephrology research and clinical excellence.

🏥 Professional Endeavors

Dr. Hansrivijit’s medical career took him to the United States, where he completed his Internal Medicine Residency at UPMC Harrisburg. This period was crucial in shaping his skills in patient diagnosis, management, and research methodologies. Currently, he is a Nephrology Fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, specializing in managing complex kidney disorders, dialysis, and transplantation. Simultaneously, he is advancing his expertise in public health through a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health.

🔬 Contributions and Research Focus

Dr. Hansrivijit has made significant contributions to the field of nephrology, particularly in chronic kidney disease, dialysis, kidney transplantation, and pharmaco-epidemiology. His research spans multiple areas, including machine learning applications in kidney disease prediction, outcomes of kidney transplant recipients, and the impact of metabolic disorders on renal health. His extensive list of publications reflects his dedication to evidence-based medicine and improving patient outcomes.

🏆 Accolades and Recognition

Dr. Hansrivijit's groundbreaking work has earned him multiple prestigious awards, including the Best Researcher Award (2025) from both the International Environmental Awards and the International Invention Awards. His achievements also include multiple Kidney STARS Program Awards from the American Society of Nephrology, a Travel Grant Award from the International Society of Nephrology, and recognition for his contributions to global nephrology research.

🌍 Impact and Influence

Beyond his clinical and research work, Dr. Hansrivijit is an active member of the nephrology community, holding memberships in renowned organizations such as the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN). His contributions in meta-analyses, systematic reviews, and nephrology-based epidemiological research have influenced treatment strategies and policy discussions on kidney disease management worldwide.

🚀 Legacy and Future Contributions

With a growing portfolio of influential research and clinical expertise, Dr. Hansrivijit is set to become a leader in nephrology innovation. His future contributions will likely focus on improving dialysis techniques, optimizing transplant outcomes, and utilizing data-driven methodologies to enhance patient care. His dedication to advancing kidney health and public health policies ensures that his impact will be felt for generations to come.

Publications


  • 📄 Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
    Author(s): Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, Elisabetta Patorno, Julie M. Paik
    Journal: Journal of Clinical Medicine
    Year: 2025


  • 📄 A Hospice Transitions Program for Patients in the Emergency Department
    Author(s): Christopher William A. Baugh, Kei Ouchi, Jason K. Bowman, Elizabeth M. Rickerson, Mallika Lakshmi Mendu
    Journal: JAMA Network Open
    Year: 2024


  • 📄 Unpacking Contributors to CKD Incidence and Progression: Time to Move Beyond Traditional Risk Factors
    Author(s): Panupong Hansrivijit, Lipika Samal, Mallika Lakshmi Mendu
    Journal: American Journal of Kidney Diseases
    Year: 2023


  • 📄 Hepatitis E Virus Infection in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
    Author(s): Angkawipa Trongtorsak, Natapat Chaisidhivej, Kritika Yadav, Wisit Cheungpasitporn, Panupong Hansrivijit
    Journal: Journal of Investigative Medicine
    Year: 2022


  • 📄 Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients
    Author(s): Karthik Reddy Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Wisit Cheungpasitporn, Swetha Rani Kanduri
    Journal: World Journal of Hepatology
    Year: 2022